Medical News

SHERIDAN, WYOMING – November 10, 2024 – SHERIDAN, WYOMING – November 10, 2024 – Two-year-old Nicklaus is a typical toddler by day, full of energy and curiosity. But by night, he transforms into a kidney care superhero, bravely battling a chronic condition he's faced since birth.

Born prematurely with only 5% kidney function, Nicklaus's journey has been filled with challenges. A blockage in his urethra and an enlarged bladder led to a 72-day stay in the neonatal intensive care unit (NICU).

A Devastating Diagnosis and a Family's Strength

"His diagnosis was devastating. It was very hard on our family," says his mother, Kayla. "We went through a lot, and we came out stronger."

Despite the initial shock and uncertainty, Nicklaus's family has found strength and resilience in navigating his kidney care journey.

Peritoneal Dialysis: Enabling a Normal Childhood

SHERIDAN, WYOMING – November 10, 2024 – SHERIDAN, WYOMING – November 10, 2024 – Baxter, a leading name in the medtech industry, is taking bold steps to transform its supply chain, ensuring that life-saving products reach patients quickly and reliably. In the wake of the COVID-19 pandemic, which exposed vulnerabilities in global supply chains across all sectors, Baxter is investing heavily in innovation to build a more resilient and efficient system.

SHERIDAN, WYOMING – November 10, 2024 – Christopher Nelson, a service specialist at Baxter, has been inducted into the National Private Truck Council (NPTC) Driver Hall of Fame. Nelson, who is based in Earth City, Mo., has been with Baxter for 35 years and has a spotless safety record. He is one of only four drivers in the United States to receive this prestigious honor.

"Chris demonstrates daily what it truly means to Save and Sustain Lives," said Daniel Gentry, Baxter regional operations manager. "He has established valuable relationships with nurses, clinics and industry experts, and has amassed a wealth of knowledge that he gladly shares with colleagues and patients alike."

The NPTC Driver Hall of Fame recognizes drivers who have demonstrated a commitment to safety and service excellence throughout their careers. Nelson has logged more than one million miles without incident – the equivalent of driving two round trips to the moon!

SHERIDAN, WYOMING – November 10, 2024 – Akron Bio, a recognized leader in biomanufacturing, continues to expand its capabilities in the field of recombinant protein development and manufacturing. With decades of experience and an unwavering commitment to quality, Akron offers comprehensive services designed to meet the needs of clients across the biotechnology, pharmaceutical, and gene therapy industries. By combining cutting-edge technology, cGMP compliance, and a deep understanding of recombinant protein production, Akron is poised to deliver innovative solutions for complex biomanufacturing challenges.

SHERIDAN, WYOMING – November 10, 2024 – Akron Bio, a leader in biotechnology and biomanufacturing, has continued to elevate its commitment to quality and innovation with the introduction of its state-of-the-art cGMP (current Good Manufacturing Practice) facility. Located in Sheridan, Wyoming, this new facility is poised to meet the ever-growing demand for high-quality plasmid DNA production, a critical component in the development of gene therapies, vaccines, and other advanced biologics.
Akron Bio’s new facility has been meticulously designed to meet the highest regulatory standards, ensuring that every stage of its plasmid DNA production is held to the strictest quality and compliance measures. This advanced facility operates in full compliance with FDA 21 CFR Part 11 and Eudralex Vol. 4 Annex 11, ensuring that both ancillary materials and drug substances are manufactured to the highest cGMP standards.

SHERIDAN, WYOMING – November 10, 2024 – PSI Engineering, a leading provider of end-to-end pack line solutions, has announced its successful collaboration with Cardinal Health at-Home Solutions to revolutionize their outbound operations through advanced automation technology. This partnership has significantly enhanced Cardinal Health at-Home Solutions' distribution centers, enabling them to meet the growing demand for at-home medical supplies with greater efficiency and speed.
Cardinal Health at-Home Solutions, a division of Cardinal Health, plays a crucial role in providing essential medical supplies and equipment directly to approximately 5 million patients across the United States annually. These patients rely on Cardinal Health at-Home Solutions for critical products to manage chronic and serious medical conditions such as diabetes, incontinence, and more.

SHERIDAN, WYOMING – November 10, 2024 – Cardinal Health, a leading provider of healthcare products and services, today announced the launch of its Cardinal Health™ Rapid Influenza A & B Test Kit. This cost-effective, lateral flow test kit is designed to provide accurate and reliable detection of influenza A and B viruses in just 10 minutes, enabling healthcare professionals to make timely treatment decisions at the point of care.

“This test kit is an important tool for managing influenza outbreaks, especially during the flu season when rapid diagnosis is crucial for effective treatment and infection control.”

SHERIDAN, WYOMING – November 10, 2024 – In the intricate world of healthcare, ensuring the safety and efficacy of medical products is paramount. Cardinal Health, a leading healthcare services company, plays a critical role in this process through its specialized handling capabilities, including cold storage and chemical vaults. These capabilities safeguard the integrity of life-saving medicines and medical products, from the moment they leave the manufacturer to their arrival at healthcare facilities.

SHERIDAN, WYOMING – November 10, 2024 – Cardinal Health today issued a comprehensive overview of its Board of Directors’ engagement and governance related to the ongoing opioid crisis. The company underscored its commitment to addressing the epidemic’s impact and highlighted its multi-faceted approach to combating opioid misuse.
“Our Board of Directors and the entire Cardinal Health team care deeply about the devastation this epidemic of opioid misuse has caused families and communities,” the company stated. “We are proud of our work alongside others across the pharmaceutical supply chain to help address this complex national public health crisis.”   

SHERIDAN, WYOMING – November 10, 2024 – Cardinal Health (NYSE: CAH) today reported strong first quarter fiscal year 2025 results, with non-GAAP operating earnings increasing 12% to $625 million and non-GAAP diluted EPS increasing 9% to $1.88. The company also raised its fiscal year 2025 non-GAAP EPS guidance to $7.75 to $7.90, from $7.55 to $7.70.“We began fiscal 2025 by delivering strong operational and financial performance, led by the Pharmaceutical and Specialty Solutions segment,” said Jason Hollar, CEO of Cardinal Health. “The strength and resiliency of our largest and most significant business continues to shine, giving us confidence to raise our fiscal 2025 enterprise guidance only a quarter into the year. Across the business, we remain focused on executing our plan to best serve our customers and create value for our shareholders.”